The Consensus Coding Sequences of Human Breast and Colorectal Cancers is a dataset published in Science (2006). On theSindex it has a DataRank of 11.9, placing it in the top 0.7% of the data-sharing corpus. It has been cited 3,178 times, with 100 citing works in its 1-hop citation network.
Ranks in the top 1% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.2
From this paper's citation signal
Citation Network Contribution
10.7
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
NCI NIH HHS
Grant: CA 62924
NIGMS NIH HHS
Grant: GM 07309
NCRR NIH HHS
Grant: RR 017698
PHS HHS
Grant: HHSN261200433002C
NCI NIH HHS
Grant: CA 121113
NCI NIH HHS
Grant: P30-CA43703
NCI NIH HHS
Grant: CA 57345
NCI NIH HHS
Grant: CA109274
NCI NIH HHS
Grant: CA 43460
FWCI
143.14
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Generating realistic null hypothesis of cancer mutational landscapes using SigProfilerSimulator
Additional file 1 of Generating realistic null hypothesis of cancer mutational landscapes using SigProfilerSimulator
Additional file 13 of Pan-cancer analysis of the oncogenic role of discs large homolog associated protein 5 (DLGAP5) in human tumors
Additional file 13 of Pan-cancer analysis of the oncogenic role of discs large homolog associated protein 5 (DLGAP5) in human tumors
Additional file 1 of Chrysophanol inhibits of colorectal cancer cell motility and energy metabolism by targeting the KITENIN/ErbB4 oncogenic complex
Additional file 1 of Chrysophanol inhibits of colorectal cancer cell motility and energy metabolism by targeting the KITENIN/ErbB4 oncogenic complex
Additional file 1 of A role for the NPM1/PTPN14/YAP axis in mediating hypoxia-induced chemoresistance to sorafenib in hepatocellular carcinoma
Additional file 1 of A role for the NPM1/PTPN14/YAP axis in mediating hypoxia-induced chemoresistance to sorafenib in hepatocellular carcinoma
Additional file 1 of Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial
Additional file 1 of Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial